Viewpoints in Genomic Medicine

Genomics in Practice at the 2013 European Cancer Congress Dr. Maurie Markman looks at a few presentations from the 2013 European Cancer Congress that highlight the practical role of genetic testing in the management of cancer.
Experts And Viewpoints, October 2013
A Brief Look: Cancer Genomic Medicine at ASCO® 2013 Dr. Maurie Markman takes a brief look at a few presentations from ASCO 2013 that highlight the evolving role of genomics in the management of cancer.
Experts And Viewpoints, August 2013
Using the Gut Microbiome Genome to Predict Type 2 Diabetes Dr. Ali Torkamani reviews a recent study that examined changes in the gut microbiome genome in relation to changes in glucose tolerance and type 2 diabetes.
Experts And Viewpoints, July 2013
Elevated BMI vs Severe Obesity: Different Genetic Diseases? Dr. Ali Torkamani looks at 2 studies questioning whether genetics can be used to define severe obesity as a separate disease.
Experts And Viewpoints, June 2013
A Window Into the Future of Cancer Monitoring Dr. Maurie Markman reviews a recent paper that describes the use of circulating tumor DNA as a new approach to monitor response to antineoplastic therapy.
Experts And Viewpoints, April 2013
Targeted Therapy for Papillary RCC: An Uncommon Approach Dr. Maurie Markman considers a new therapy that targets an uncommon mutation in the uncommon papillary subtype of renal cell carcinoma.
Experts And Viewpoints, March 2013
Trastuzumab Resistance: Can Genetics Lead Us to New Options? Dr. Maurie Markman looks at how research into genetic changes in trastuzumab-resistant breast cancers might open the door to new treatment options.
Experts And Viewpoints, January 2013
Genetic Underpinnings of IBD: Immunity, Infection, and More Dr. Dermot McGovern reviews a recent meta-analysis of genetic studies of inflammatory bowel disease and its links to immune diseases, mycobacterial infections, and more.
Experts And Viewpoints, January 2013
Progress in Cancer Genomic Medicine: A Year in Review, 2012 Dr. Maurie Markman looks back at key research studies from 2012 and discusses how they affect our understanding of the role of cancer genomics in clinical practice.
Experts And Viewpoints, December 2012
Should We Test Lp(a) to Predict Risk for Atherosclerosis? Dr Deepak Voora considers the clinical implications of recent data demonstrating an association between lipoprotein(a) levels and atherosclerosis.
Experts And Viewpoints, December 2012
Targeted Therapies on the Horizon for Squamous Lung Cancers Dr. Maurie Markman considers the clinical and therapeutic consequences of the first-ever genomic characterization of squamous lung cancers.
Experts And Viewpoints, November 2012
Genetic Tracking of an Infection Outbreak: The Future Is Now Dr. Christopher Woods looks at the use of whole genome sequencing to track an infection outbreak in a research hospital and considers when this technology might be available in clinical practice.
Experts And Viewpoints, November 2012
Genetic Biomarker for Taxane-Induced Neuropathy Dr. Maurie Markman looks at a recent study that identified a genetic marker significantly associated with taxane-induced peripheral neuropathy.
Experts And Viewpoints, November 2012
Squaring Genetic vs Clinical Findings in Familial Polyposis What should we do if the genetics and clinical presentation don't align in patients with familial adenomatous polyposis? Dr. Ora Gordon and genetic counselor Tali Geva weigh in.
Experts And Viewpoints, October 2012
EGFR Mutation Status and TKI Use in NSCLC: The Final Word Should EGFR TKIs be considered in patients with advanced NSCLC if mutation status is unknown? Dr. Maurie Markman reviews a study that offers the final word.
Experts And Viewpoints, September 2012
Preventing Head and Neck Tumors the Genetic Way Chemoprevention of head and neck cancers with retinoic acid showed mixed trial results. But as Dr. Maurie Markman explains, genetics might help in predicting responders.
Experts And Viewpoints, August 2012
Type 2 Diabetes in Lean Individuals: A Different Disease? Type 2 diabetes is associated with obesity, but lean individuals develop the disease as well. Dr. Ali Torkamani reviews a recent paper implicating unique genetic variants in lean diabetics.
Experts And Viewpoints, August 2012
CLL Genomics: Converting a Prognostic Factor Into a Target TP53 deletion is known to be an adverse prognostic factor in patients with chronic lymphocytic leukemia. Dr. Maurie Markman looks at how it can be used as a target for therapy.
Experts And Viewpoints, July 2012
Gene Therapy for HIV Drs. Scott Kitchen and Jerome Zack discuss how genetically modifying peripheral T cells and other gene therapy approaches might prove useful in the clinic.
Experts And Viewpoints, June 2012
Olaparib in Ovarian Cancer: Parsing the Data A phase 2 trial of olaparib showed improvements in PFS but not OS in patients with ovarian cancer. Dr. Maurie Markman explains why.
Experts And Viewpoints, June 2012

Viewpoints in Genomic Medicine

About

Membership

Apps

WebMD Network

Editions

Viewpoints in Genomic Medicine

Find Us On

About

Membership

Apps

WebMD Network

Editions